November 2024
Advancing Medical Applications of Cancer Nanotechnology
The Nanotechnology Characterization Laboratory (NCL) has made significant strides in advancing cancer nanotechnology over the past two decades. Established by the National Cancer Institute in 2004 in collaboration with the US Food and Drug Administration and the National Institute of Standards and Technology, NCL has played a crucial role in bridging the gap between nanotechnology innovations and their clinical applications in oncology. To celebrate two successful decades of NCL’s contributions to advancing the field of cancer nanotechnology, this symposium brings together NCL…
Find out more »Advancing Medical Applications of Cancer Nanotechnology
The Nanotechnology Characterization Laboratory (NCL) has made significant strides in advancing cancer nanotechnology over the past two decades. Established by the National Cancer Institute in 2004 in collaboration with the US Food and Drug Administration and the National Institute of Standards and Technology, NCL has played a crucial role in bridging the gap between nanotechnology innovations and their clinical applications in oncology. To celebrate two successful decades of NCL’s contributions to advancing the field of cancer nanotechnology, this symposium brings together NCL…
Find out more »Advancing Medical Applications of Cancer Nanotechnology
The Nanotechnology Characterization Laboratory (NCL) has made significant strides in advancing cancer nanotechnology over the past two decades. Established by the National Cancer Institute in 2004 in collaboration with the US Food and Drug Administration and the National Institute of Standards and Technology, NCL has played a crucial role in bridging the gap between nanotechnology innovations and their clinical applications in oncology. To celebrate two successful decades of NCL’s contributions to advancing the field of cancer nanotechnology, this symposium brings together NCL…
Find out more »